Dna X (SONM) Inventory (2018 - 2025)

Dna X has reported Inventory for 8 years, with the latest figure at $11.0 million in Q3 2025.

• For the quarter ending Q3 2025, Inventory fell 11.22% year-over-year to $11.0 million; the trailing twelve-month figure through Sep 2025 stood at $11.0 million (down 11.22% YoY), and the FY2024 full-year result was $10.6 million, up 62.97% from the prior year.
• Inventory for Q3 2025 stood at $11.0 million, up from $9.9 million in the prior quarter.
• The five-year high for Inventory was $12.4 million in Q3 2024, with the low at $185000.0 in Q4 2021.
• Historically, Inventory has averaged $7.0 million across 5 years, with a median of $6.5 million in 2023.
• The largest YoY upside for Inventory was 2013.51% in 2022 against a maximum downside of 71.27% in 2022.
• Dna X's Inventory stood at $185000.0 in 2021, then soared by 2013.51% to $3.9 million in 2022, then soared by 66.68% to $6.5 million in 2023, then surged by 62.97% to $10.6 million in 2024, then climbed by 3.44% to $11.0 million in 2025.
• The last three Inventory figures came in at $11.0 million (Q3 2025), $9.9 million (Q2 2025), and $8.6 million (Q1 2025), per Business Quant data.